Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Similar documents
Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Update on Reporting Prostate Cancer Pathology

Uropathology January Jon Oxley

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Prostate Overview Quiz

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

They Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples

Breast pathology. 2nd Department of Pathology Semmelweis University

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Current Clinical Practice. MR Imaging Evaluations. MRI Anatomic Review. Imaging to Address Clinical Challenges. Prostate MR

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies

Surgical Pathology Issues of Practical Importance

2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Diagnosis, pathology and prognosis including variant pathology

PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

A re-audit of Prostate biopsies from January to December 2010 and 2013.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Flat Epithelial Atypia

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Benign Breast Disease and Breast Cancer Risk

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES

Minimizing Errors in Diagnostic Pathology

BPH with persistently elevated PSA 아주대학교김선일

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Chapter 2. Understanding My Diagnosis

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

The role of the cytologist in breast cancer screening

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

The Role of the Pathologist Active Surveillance for Prostate Cancer

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

Some prostatic diseases

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa)

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Basement membrane in lobule.

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Grading Prostate Cancer: Recent Changes and Refinements

Elevated PSA. Dr.Nesaretnam Barr Kumarakulasinghe Associate Consultant Medical Oncology National University Cancer Institute, Singapore 9 th July 2017

Neoplasms of the Prostate and Bladder

Breast Pathology. Breast Development

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

ADENOCARCINOMA OF THE PROSTATE

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

Prostate Case Scenario 1

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

BREAST PATHOLOGY. Fibrocystic Changes

When to worry, when to test?

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Papillary Lesions of the breast

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Guidance on the management of B3 lesions

CNB vs Surgical Excision

FINALIZED SEER SINQ QUESTIONS

Evaluation of Breast Specimens Removed by Needle Localization Technique

Atypical proliferative lesions diagnosed on core biopsy - 6 year review

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Mammography and Other Screening Tests. for Breast Problems

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Enterprise Interest None

Breast Evaluation & Management Guidelines

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

Prostate Cancer 3/15/2017. CEUS of the Prostate. The Prostate Cancer Screening Dilemma Data. Incidence: 161,360 Deaths: 26,730

Recommendations for the Reporting of Prostate Carcinoma

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

STEREOTACTIC BREAST BIOPSY: CORRELATION WITH HISTOLOGY

MEDICAL POLICY Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of

Prostate Biopsy. Prostate Biopsy. We canʼt go backwards: Screening has helped!

TOPICS FOR DISCUSSION

Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy

10/2/2018 OBJECTIVES PROSTATE HEALTH BACKGROUND THE PROSTATE HEALTH INDEX PHI*: BETTER PROSTATE CANCER DETECTION

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.

3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma???

BAYESIAN JOINT LONGITUDINAL-DISCRETE TIME SURVIVAL MODELS: EVALUATING BIOPSY PROTOCOLS IN ACTIVE-SURVEILLANCE STUDIES

Prostate Cancer Incidence

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Transcription:

Concepts in Prostate Pathology Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Outline (1) Peculiarities of prostate cancer Peculiarities of prostate needle biopsy Needle bx vs. TURP Prostate cancer vs. breast cancer Prostate needle bx vs. breast needle bx Outline (2) High-grade PIN Clinical significance Suspicious for malignancy All ASAPs are not the same Accuracy vs. reproducibility Processing needle bx Rationale for examining levels Peculiarities of Prostate Cancer High incidence of clinically insignificant cancer that old men die with Prostate cancer in up to 80% of men at age 80 Bx protocols that pick up all cancers may do more harm than good Peculiarities of Prostate Cancer Racial predilection African-Americans have highest incidence and mortality rate? Genetic? Diet (red meat)? Access to health care Followed by Caucasians, Hispanics, Asians Alaska natives. Peculiarities of Prostate Cancer Racial predilection (contd) Implications for literature analysis Cancer pick-up and survival rates vary depending on population studied Original Partin Tables may not be applicable to African-Americans only 6% in the cohort studied 1

Peculiarities of Prostate Cancer Only a carefully selected proportion of pts undergo radical prostatectomy Accurate grade and stage data available only for this sub-group Data from this sub-group extrapolated to general population (eg. Partin s table) Few high-grade cancers (Gleason 8-10) in radicals Confidence limits for high-grade cancer in nomograms is wider Zonal Anatomy: McNeal s model CZ: Central zone PZ: Peripheral zone TZ: Transition zone Fm: Anterior fibromuscular stroma Bn: Bladder neck Zonal Anatomy: Simplified Transition zone Peripheral zone Zonal Anatomy Transition zone Inner gland Site of origin of BPH nodules Transition zone cancer Generally low grade, low volume Good prognosis Sampled by TURP Zonal Anatomy Peripheral zone Outer gland Peripheral zone cancer Clinically significant cancer Sampled by needle bx Area sampled Cancer Small volume, Gleason 2-4 PIN Architecture Benign lesions TURP Periurethral (transition zone) Ductal Generally clinically insignificant Rare Easier to appreciate Nephrogenic adenoma, sclerosing adenosis, Clear cell cribriform hyperplasia Needle bx Peripheral zone, posterior Microacinar Often significant (so no Gleason <5) 5% May be difficult Seminal vesicle/ Ejaculatory duct 2

Peculiarities of Prostate Needle Bx Problems with Needle Bx Dx Most needle biopsies non-targeted Clinical/radiological/biochemical tests have low accuracy Bx has to carefully screened for tiny suspect foci Minimal cancer in bx does not equate to low volume prostate cancer Tip of the Iceberg Breast bx Prostate bx Problems with Needle Bx Dx Prostate cancer often multifocal Cancer in bx may not be dominant tumour Implications for studies of prognostic markers Cancer often not apparent on macroscopic examination of radical prostatectomy specimen Some cancers may still not be found even after specimen is all submitted: vanishing prostate cancer Problems with Needle Bx Dx Significant false negative rate All patients with benign biopsies must be followed up with serum PSA Only 2 management decisions based on histology Repeat biopsy Radical therapy Advising PSA follow-up based on biopsy findings is irrelevant Problems with Needle Bx Dx Significant sampling error Apparent grade or tumour volume progression on active surveillance may be due to undersampling in the previous bx Pattern 4 in re-bx had been missed in original 3+3=6 biopsy rather than representing disease progression 3

Problems with Needle Bx Dx suspicious for cancer cases cannot be easily resolved by re-biopsy or local excision Gold Standard for Needle Biopsy Dx Not repeat biopsy Benign repeat bx may be false negative Cancer in repeat bx may be unrelated to the initial suspicious focus Not radical prostatectomy Vanishing prostate cancer Only gold standard is THAT biopsy Prostate Cancer vs. Breast Cancer Similarities Prostate Cancer vs. Breast Cancer Differences BREAST PROSTATE BREAST PROSTATE Gender predominance Female Male Hormone dependence Oestrogen Androgen Some clinically insignificant Tubular carcinoma Transitional zone Screen detectable Mammography Serum PSA Hormonal manipulation Tamoxifen Androgen ablation In situ DCIS PIN in situ vs. invasive Myoepithelial cells Basal cells (H/E and immuno) (H/E and immuno) Palpable Tm Often yes Generally not Radiol. localisatn Reliable Unreliable Needle bx Targeted Non-targeted Excision bx Possible Not possible Serum marker None PSA Final staging Generally Often only histological clinico-radiological Prostate Cancer vs. Breast Cancer DCIS Often segmental Treated by excision because precursor of cancer High-grade PIN Generally multifocal Less important as precursor lesion Elderly patients PIN takes years to develop into cancer Cancer takes years to become clinically significant Surrogate marker for missed cancer Immediate repeat biopsy 4

High-grade PIN Extended bx protocols have lower false negative rate No need for repeat bx? More comparable with LCIS than DCIS Not necessary to report if cancer present Low-grade PIN Low risk of cancer in repeat bx Poor reproducibility Do not include in report Three Different ASAPs 1) Adenosis cannot exclude cancer 2) Cancer cannot exclude adenosis 3)? Intraductal carcinoma Three Different Scenarios with Different Clinical Implications 1) Cancer reported as suspicious Delay in diagnosis Limited clinical impact Prostate cancer is indolent disease 1 core 3+3 cancer may not require Rx (NICE guidelines in the UK) Some centres would not re-bx (PSA F/U) Three Different Scenarios with Different Clinical Implications 2) Adenosis reported as suspicious Repeat biopsy, follow-up, anxiety Three Different Scenarios with Different Clinical Implications 3)? Intraductal carcinoma Delay in diagnosis Significant clinical impact Cancers with intra-ductal extension are generally aggressive tumours Immediate repeat biopsy mandatory? Radical Rx: surgery/radiorx) 5

Reproducibility vs. Accuracy Reproducibility = getting the same answer every time (right or wrong) Accuracy = the right answer Very difficult to determine Many of the criteria in the literature are about improving reproducibility rather than accuracy Reproducibility Studies Depends on Choice of participants Intra-observer Intra-departmental National International Choice of cases Classic Borderline Processing Prostate biopsies Why Process Prostate Bx Differently as Compared to Other Biopsies? Prostate cancers often small and not localised by clinical/trus examination Limited cancer in prostate bx = minimal prostate cancer suspicious for cancer cases cannot be easily resolved by re-biopsy or local excision 18 gauge prostate biopsies thin and easily fold (cf. firmer thicker breast bx) Breast vs. prostate needle bx (2x magnification) 18 Gauge Prostate Biopsies are Thin and Difficult to Embed Flat in a Single Plane Breast Prostate 6

Cutting Too Deep in First Level Could Result in Permanent Tissue Loss 1 2 3 Cardiff Bx Processing Protocol Cores processed separately Easier to embed flat Avoids overlapping cores Avoids cores embedded in different planes Permits adoption on targeted strategy for repeat biopsy 3 levels examined by H&E Unstained sections from each level saved for immunohistochemistry Small foci often cut out in Deeper levels Tissue ribbons Level 1 Level 2 Level 3 Glass slides H&E Immuno Spares Cardiff protocol: Advantages Biopsy embedded flat and examined along entire length Our MLSOs prefer embedding biopsies separately Only 1 slide/block Advantages (contd) Section in straight line so easier to screen 7

Advantages (contd) Immunostained section corresponds more closely with H&E section Cardiff protocol: Drawbacks More blocks to cut More blocks to store At least 10 per case More unstained slides to store Necessary to store indefinitely? Rationale for examining levels 1. To find cancer deeper in core 2. To examine entire length of core If cores embedded flat, 2 levels may be adequate Prostate Cancer and Evidence Based Medicine It is better to have no ideas than false ones; to believe nothing than to believe what is wrong -Thomas Jefferson Bad evidence is worse than no evidence as it can result in inappropriate treatment and preclude search for better evidence 8